| Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes DE Benn, AP Gimenez-Roqueplo, JR Reilly, J Bertherat, J Burgess, ... The Journal of Clinical Endocrinology & Metabolism 91 (3), 827-836, 2006 | 708 | 2006 |
| Factitious Graves’ disease due to biotin immunoassay interference—a case and review of the literature MS Elston, S Sehgal, S Du Toit, T Yarndley, JV Conaglen The Journal of Clinical Endocrinology & Metabolism 101 (9), 3251-3255, 2016 | 162 | 2016 |
| Wnt pathway inhibitors are strongly down-regulated in pituitary tumors MS Elston, AJ Gill, JV Conaglen, A Clarkson, JM Shaw, AJJ Law, RJ Cook, ... Endocrinology 149 (3), 1235-1242, 2008 | 118 | 2008 |
| Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A) M Houang, A Clarkson, L Sioson, MS Elston, RJ Clifton-Bligh, M Dray, ... Human Pathology 44 (12), 2711-2718, 2013 | 102 | 2013 |
| Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas MS Elston, AJ Gill, JV Conaglen, A Clarkson, RJ Cook, NS Little, ... The Journal of Clinical Endocrinology & Metabolism 94 (4), 1436-1442, 2009 | 96 | 2009 |
| Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features AJ Gill, G Lim, VKY Cheung, J Andrici, JL Perry-Keene, J Paik, L Sioson, ... The American journal of surgical pathology 43 (1), 35-46, 2019 | 92 | 2019 |
| Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations DL Learoyd, J Gosnell, MS Elston, TJ Saurine, AL Richardson, ... Clinical endocrinology 63 (6), 636-641, 2005 | 79 | 2005 |
| Increased SSTR2A and SSTR3 expression in succinate dehydrogenase–deficient pheochromocytomas and paragangliomas MS Elston, GY Meyer-Rochow, HM Conaglen, A Clarkson, ... Human pathology 46 (3), 390-396, 2015 | 77 | 2015 |
| Familial pituitary tumor syndromes MS Elston, KL McDonald, RJ Clifton-Bligh, BG Robinson Nature Reviews Endocrinology 5 (8), 453-461, 2009 | 65 | 2009 |
| Paraganglioma in pregnancy: a case series and review of the literature LA Wing, JV Conaglen, GY Meyer-Rochow, MS Elston The Journal of Clinical Endocrinology & Metabolism 100 (8), 3202-3209, 2015 | 55 | 2015 |
| Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer B Lawrence, C Blenkiron, K Parker, P Tsai, S Fitzgerald, P Shields, ... NPJ genomic medicine 3 (1), 18, 2018 | 53 | 2018 |
| Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years AR Al Subhi, V Boyle, MS Elston Journal of the Endocrine Society 6 (9), bvac105, 2022 | 47 | 2022 |
| Early Onset Primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B MS Elston, GY Meyer-Rochow, M Dray, M Swarbrick, JV Conaglen Case Reports in Endocrinology 2015 (1), 510985, 2015 | 44 | 2015 |
| Thyrotoxic, hypokalaemic periodic paralysis: Polynesians, an ethnic group at risk MS Elston, BJ Orr‐Walker, AM Dissanayake, JV Conaglen Internal medicine journal 37 (5), 303-307, 2007 | 44 | 2007 |
| Absence of myostatin improves cardiac function following myocardial infarction S Lim, CD McMahon, KG Matthews, GP Devlin, MS Elston, JV Conaglen Heart, Lung and Circulation 27 (6), 693-701, 2018 | 40 | 2018 |
| Adherence to adrenal incidentaloma guidelines is influenced by radiology report recommendations BN Wickramarachchi, GY Meyer‐Rochow, K McAnulty, JV Conaglen, ... ANZ journal of surgery 86 (6), 483-486, 2016 | 40 | 2016 |
| Thyroid cancer in G raves’ disease: is surgery the best treatment for G raves’ disease? JAU Tamatea, K Tu'akoi, JV Conaglen, MS Elston, GY Meyer‐Rochow ANZ journal of surgery 84 (4), 231-234, 2014 | 40 | 2014 |
| Symptoms and signs of acromegaly: an ongoing need to raise awareness among healthcare practitioners R Zarool-Hassan, HM Conaglen, JV Conaglen, MS Elston Journal of primary health care 8 (2), 157-163, 2016 | 38 | 2016 |
| A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery MS Elston, IJ Stewart, R Clifton-Bligh, JV Conaglen Bone 40 (1), 236-241, 2007 | 34 | 2007 |
| Duration of cortisol suppression following a single dose of dexamethasone in healthy volunteers: a randomised double-blind placebo-controlled trial MS Elston, HM Conaglen, C Hughes, JAU Tamatea, GY Meyer-Rochow, ... Anaesthesia and intensive care 41 (5), 596-601, 2013 | 33 | 2013 |
